Notable Insider Buys Of The Past Week: Mylan, Sonabank, Steak 'N Shake, U-Haul, And More

A director at Burlingame, California-based ALX Oncology Holdings Inc. (ALXO) indirectly purchased 20,000 shares in a secondary offering. At the offering price of $76 per share, the total for this transaction came to $1.52 million. The purchase brought the stake to 995,000 shares, as well.

An executive stepped up to the buy window last week and paid $11.46 to $11.84 each for 126,000 Grid Dynamics Holdings Inc. (GDYN) shares. That cost the executive more than $1.47 million, and it brought her stake in this California-based IT company to more than 277,800 shares.

The owner of Steak 'n Shake and Maxim magazine, Biglari Holdings Inc. (BH), saw CEO Sardar Biglari add 4,520 additional shares to his stake. At $118.00 (for class B shares) to $630.00 (class A shares), that cost Biglari more than $1.01 million. His stake is listed as up to more than 816,300 shares.

Athene Holding Ltd. (ATH) CEO Richard Belardi indirectly bought more than 40,000 Series D Preference Shares late last week. At $25 per share, that cost him about $1 million. This purchase came in the wake of the announcement of a pension buyout agreement with GE.

Viatris Inc. (VTRS), formerly known as Mylan, had a director purchase more than 27,700 shares in the middle of the week. At per-share prices ranging from $17.57 to $17.73, that cost him nearly $489,700. The shares ended the week at $17.75. Mylan merged with Upjohn, a division of Pfizer (PFE), in November.

Two Stonex Group Inc. (SNEX) officers acquired almost 16,000 shares of this financial services company altogether last week. At $50.79 to $53.19 per share, these transactions totaled about $828,900. The stock was last seen changing hands at $56.00 per share.

Note that there also was some smaller amount of insider buying at Broadcom Inc. (AVGO), Citi Trends, Inc. (CTRN), Curiositystream Inc. (CURI), National Health Investors Inc. (NHI), and TransDigm Group Incorporated (TDG) reported last week.

1 2
View single page >> |

Disclaimer: At the time of this writing, the author had no position in the mentioned equities.

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.